Soru

Zorluk: OrtaPsychopharmacology and Psychological Therapies

Match each patient presenting with major depressive disorder to the most appropriate first-line pharmacologic treatment based on their specific comorbidities and symptom profile.

  • A 62-year-old man seeking psychiatric treatment one month after an acute myocardial infarction.Sertraline
  • A 34-year-old man exhibiting severe fatigue, hypersomnolence, and expressing a strong desire to quit smoking.Bupropion
  • A 28-year-old woman suffering from severe insomnia, poor appetite, and unwanted weight loss over the past two months.Mirtazapine
  • A 41-year-old woman who has a history of poorly controlled diabetes and complains of burning, painful peripheral neuropathy.Duloxetine

Cevap

Match the post-MI patient to Sertraline, the fatigued smoker to Bupropion, the patient with insomnia and weight loss to Mirtazapine, and the diabetic neuropathy patient to Duloxetine.
Each correct match utilizes the unique pharmacokinetic and pharmacodynamic properties of the antidepressants to simultaneously treat the patient's major depressive disorder and their specific comorbid symptoms, optimizing the therapeutic response while minimizing adverse effects.

Adım Adım Çözüm

1
Evaluate the 62-year-old man post-MI.
Identify the need for an antidepressant with high cardiovascular safety.
Post-MI patients are vulnerable to arrhythmias and drug interactions with cardiac medications; Sertraline is the safest evidence-based choice.
2
Evaluate the 34-year-old man with fatigue and smoking history.
Select Bupropion.
Bupropion's dopaminergic and noradrenergic effects counteract fatigue, and it independently aids in smoking cessation.
3
Evaluate the 28-year-old woman with insomnia and weight loss.
Select Mirtazapine.
Mirtazapine's adverse effects of weight gain and sedation are highly therapeutic for this specific clinical presentation.
4
Evaluate the 41-year-old woman with diabetic neuropathy.
Select Duloxetine.
SNRIs like Duloxetine treat both depression and neuropathic pain effectively through modulation of descending pain pathways.

Anahtar Kavram

Tailoring antidepressant therapy based on side-effect profiles and medical comorbidities.
Bu soruyu puanla